HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression of focal adhesion kinase and alpha5 and beta1 integrins in carcinomas and its clinical significance.

AbstractAIM:
To detect the expression pattern of FAK (focal adhesion kinase) and integrin alpha5 and beta1 subunits in different kinds of cancerous tissues and to study their correlation with clinicopathological data including tumor type, grade and lymph node status.
METHODS:
Using an immunohistochemical technique, we examined the expression of FAK and integrin and subunits in cancerous and noncancerous tissues obtained from 75 patients with gastric carcinomas, 21 colorectal carcinomas, 16 hepatocellular carcinomas, 20 uterocervical carcinomas, and 20 breast carcinomas.
RESULTS:
The staining of FAK was stronger in cancerous than in noncancerous areas. Enhanced expression of FAKwas detected in poor-differentiated carcinoma of the stomach and colorectum. Tumors with lymph node metastases had more FAK protein than those without metastases. In addition, the deeper the extent of tumor infiltration, the higher the FAK expression. The expression of integrin alpha5 and beta1 subunits was lower in cancerous areas than in noncancerous areas, but it was higher in well-differentiated cancerous tissues than in poor differentiated tissues. The relationship between the expression of integrin alpha5 and beta1 subunits and infiltration or metastasis was not significant. Cancerous tissues with stronger FAK expression (++ or +++) also had a higher expression of integrin alpha5 and beta1 subunits in the tumor and its unaffected margins.
CONCLUSION:
FAK is a better marker for carcinogenesis and the progression of cancer than integrin alpha5 and beta1 subunit, and it may be not only a transformation-linked enzyme but also a progression-linked enzyme.
AuthorsJian-Min Su, Lu Gui, Yi-Ping Zhou, Xi-Liang Zha
JournalWorld journal of gastroenterology (World J Gastroenterol) Vol. 8 Issue 4 Pg. 613-8 (Aug 2002) ISSN: 1007-9327 [Print] United States
PMID12174366 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, CD
  • Integrin alpha5
  • Integrin beta1
  • Protein-Tyrosine Kinases
  • Focal Adhesion Kinase 1
  • Focal Adhesion Protein-Tyrosine Kinases
  • PTK2 protein, human
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Antigens, CD (metabolism)
  • Breast Neoplasms (metabolism, pathology)
  • Colorectal Neoplasms (metabolism, pathology)
  • Female
  • Focal Adhesion Kinase 1
  • Focal Adhesion Protein-Tyrosine Kinases
  • Humans
  • Integrin alpha5
  • Integrin beta1 (metabolism)
  • Liver Neoplasms (metabolism, pathology)
  • Male
  • Middle Aged
  • Neoplasms (metabolism, pathology)
  • Protein-Tyrosine Kinases (metabolism)
  • Stomach Neoplasms (metabolism, pathology)
  • Uterine Neoplasms (metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: